ReviewJournal of the American College of Cardiology2018
Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review.
Review in Journal of the American College of Cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05793008 (Characterization of priMary And sEcondary STress Related takOtsubo), which is not on this map. Cited by 287 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Characterization of priMary And sEcondary STress Related takOtsubo: the MAESTRO Pilot Study
Who cites it
287 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Predictors of high-grade atrioventricular block recovery in Takotsubo cardiomyopathy: a systematic review of case reports.Open heart · 2026Pooled it
- A systematic review on focal takotsubo syndrome: a not-so-small matter.Heart failure reviews · 2022Pooled it
- Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis.The American journal of emergency medicine · 2021Pooled it
- Risk of in-hospital life-threatening ventricular arrhythmia or death after ST-elevation myocardial infarction vs. the Takotsubo syndrome.ESC heart failure · 2021Pooled it
- Diagnostically Challenging Cardiac Myxoma Presenting as Acute Myocardial Infarction.JACC. Case reports · 2026Article
- A primary isolated heart model of Takotsubo syndrome for mechanistic investigation and preclinical therapeutic testing.European heart journal open · 2026Article
- Neuroimaging biomarkers of the brain-heart axis in Takotsubo syndrome: regional convergence without directional consistency: a systematic review and biomarker qualification appraisal.Acta neurologica Belgica · 2026Review
- A Rare Case of Takotsubo Cardiomyopathy Recurrence With Alternate Reverse Phenotypes.The American journal of case reports · 2026Article
- Article
- Spontaneous Coronary Artery Dissection and Takotsubo Syndrome: Converging Mechanisms, Diagnostic Pitfalls, and a Unified Clinical Algorithm.Journal of clinical medicine · 2026Review
- A Case of Peripartum Cardiogenic Shock Resulting From Reverse Takotsubo Cardiomyopathy.Journal of medical cases · 2026Article
- Stress-Induced (Takotsubo) Cardiomyopathy Associated With Upadacitinib Induction Therapy in Severe Crohn's Disease.ACG case reports journal · 2026Article
- Coronary Microvascular Dysfunction in Stress Cardiomyopathy: At the Heart of the Problem.Life (Basel, Switzerland) · 2026Review
- Isolated Right Ventricular Takotsubo Cardiomyopathy: Beyond the Left Ventricle.JACC. Case reports · 2026Article
- Cancer therapy-associated Takotsubo cardiomyopathy: A narrative review of mechanisms, drug associations, and clinical implications.American heart journal plus : cardiology research and practice · 2026Review
- Article
- Did COVID and Low Sodium Break My Heart?Cureus · 2026Article
- Exercise stress cardiomyopathy-a case report.European heart journal. Case reports · 2026Article
- The Role of Inflammation in Takotsubo Syndrome: From Pathogenic Pathways To Imaging Insights and Therapeutic Perspectives.Current cardiology reports · 2026Review
- Amphetamine-induced Reverse Takotsubo Cardiomyopathy and Thrombosis: A Case Report.Clinical practice and cases in emergency medicine · 2026Article
227 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Stress cardiomyopathy is an acute reversible heart failure syndrome initially believed to represent a benign condition due to its self-limiting clinical course, but now recognized to be associated with a non-negligible rate of serious complications such as ventricular arrhythmias, systemic thromboembolism, and cardiogenic shock. Due to an increased awareness and recognition, the incidence of stress cardiomyopathy has been rising (15-30 cases per 100,000 per year), although the true incidence is unknown as the condition is likely underdiagnosed. Stress cardiomyopathy represents a form of neurocardiogenic myocardial stunning, and while the link between the brain and the heart is established, the exact pathophysiological mechanisms remain unclear. We herein review the proposed risk factors and triggers for the syndrome and discuss a practical approach to diagnosis and treatment of the patients with stress cardiomyopathy, highlighting potential challenges and unresolved questions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.